Autophagy and its comprehensive impact on ALS

International Journal of Neuroscience

Volumn 122, Issue 12, 2012, Pages 695-703

  Song, Cheng Yuan ^a   Guo, Ji Feng ^a,b   Liu, Yuan ^b   Tang, Bei Sha ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

amyotrophic lateral sclerosis; autophagic flux; autophagy; SOD1; TDP 43

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; LITHIUM; MAMMALIAN TARGET OF RAPAMYCIN; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN P62; RAPAMYCIN; TAR DNA BINDING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOPHAGY; CELL GROWTH; CELL MATURATION; CHAPERONE-MEDIATED AUTOPHAGY; DISEASE MODEL; ENDOPLASMIC RETICULUM STRESS; GENE MUTATION; HOMEOSTASIS; HUMAN; LYSOSOME; NERVE DEGENERATION; NONHUMAN; SPINAL CORD;

AMYOTROPHIC LATERAL SCLEROSIS; AUTOPHAGY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MICROTUBULE-ASSOCIATED PROTEINS; MUTATION; SIROLIMUS; SUPEROXIDE DISMUTASE;

EID: 84869742069     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2012.714430     Document Type: Article

References (84)

1. Rowland LP. Amyotrophic lateral sclerosis. Curr Opin Neurol. 1994;7:310-15.
2. Ciechanover A. The ubiquitin proteolytic system: From a vague idea, through basic mechanisms, and onto human diseases and drug targeting. Neurology. 2006;66:7-19.
3. Ferrucci M, Fulceri F, Toti L, Soldani P, Siciliano G, Paparelli A, Fornai F. Protein clearing pathways in ALS. Archives Italiennes de Biologie. 2011;149:121-49.
4. Tan JM, Wong ES, Kirkpatrick DS, Pletnikova O, Ko HS, Tay SP, HoMW, Troncoso J, Gygi SP, Lee MK, Dawson VL, Dawson TM, Lim KL. Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum Mol Genet. 2008;17:431-9.
5. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF,Duden R,O'KaneCJ, RubinszteinDC. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 2004;36:585-95.
6. Tain LS,Mortiboys H, Tao RN, Ziviani E, Bandmann O,Whitworth AJ. Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss. Nat Neurosci. 2009;12:1129-35.
7. Glick D, Barth S, Macleod KF. Autophagy: Cellular and molecular mechanisms. J Pathol. 2010;221:3-12.
8. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science. 2000;290:1717-21.
9. Kirkin V, McEwan DG, Novak I, Dikic I. A role for ubiquitin in selective autophagy. Mol Cell. 2009;34:259-69.
10. Sarkar S, Ravikumar B, Rubinsztein DC. Autophagic clearance of aggregate-prone proteins associated with neurodegeneration. Methods Enzymol. 2009;453:83-110.
11. Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, Mizushima N, Iwata J, Ezaki J, Murata S, Hamazaki J, Nishito Y, Iemura S, Natsume T, Yanagawa T, Uwayama J, Warabi E, Yoshida H, Ishii T, Kobayashi A, Yamamoto M, Yue Z, Uchiyama Y, Kominami E, Tanaka K. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagydeficient mice. Cell. 2007;131:1149-63.
12. Zheng YT, Shahnazari S, Brech A, Lamark T, Johansen T, Brumell JH. The adaptor protein p62/SQSTM1 targets invading bacteria to the autophagy pathway. J Immunol. 2009;183:5909-16.
13. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Øvervatn A, Bjørkøy G, Johansen T. p62/SQSTM1 binds directly toAtg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282:24131-145.
14. Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y. Dynamics and diversity in autophagy mechanisms: Lessons from yeast. Nat Rev Mol Cell Biol. 2009;10:458-67.
15. Nazarko VY, Nazarko TY, Farre JC, Stasyk OV, Warnecke D, Ulaszewski S, Cregg JM, Sibirny AA, Subramani S. Atg35, a micropexophagy-specific protein that regulates micropexophagic apparatus formation in Pichiapastoris. Autophagy. 2011;7:375-85.
16. Mizushima N. Autophagy: Process and function. Genes Dev. 2007;21:2861-73.
17. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000;19:5720-5728.
18. Eskelinen EL. Maturation of autophagic vacuoles in mammalian cells. Autophagy. 2005;1:1-10.
19. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 2009;43:67-93.
20. Cuervo, AM. Chaperone-mediated autophagy: selectivity pays off. Trends Endocrinol Metab. 2010;21:142-150.
21. KonM, Cuervo AM. Chaperone-mediated autophagy in health and disease. FEBS Lett. 2010;584:1399-1404.
22. D'iaz-Troya S, P'Erez-P'Erez ME, Florencio FJ, Crespo JL. The role of TOR in autophagy regulation from yeast to plants and mammals. Autophagy. 2008;4:851-65.
23. Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger PA, Small S, Spencer B, Rockenstein E, Levine B, Wyss-Coray T. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest. 2008;118(6): 2190-99.
24. Shibata M, Lu T, Furuya T, Degterev A, Mizushima N, Yoshimori T, MacDonald M, Yankner B, Yuan J. Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1. J Biol Chem. 2006;281:14474-85.
25. Erlich S, Shohami E, Pinkas-Kramarski R. Neurodegeneration induces upregulation of Beclin 1. Autophagy. 2006;2:49-51.
26. Petiot A, Ogier-Denis E, Blommaart EF, Meijer AJ, Condogno P. Distinct classes of phosphatidylinositol 30-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem. 2000;275:992-8.
27. Waterman-Storer CM, Karki SB, Kuznetsov SA, Tabb JS,Weiss DG, Langford GM, Holzbaur EL. The interaction between cytoplasmic dynein and dynactin is required for fast axonal transport. Proc Natl Acad Sci USA. 1997;94:12180-85.
28. Yamamoto M, Suzuki SO, Himeno M. The effects of dynein inhibition on the autophagic pathway in glioma cells. Neuropathology. 2010;30:1-6.
29. Cai Q, Lu L, Tian JH, Zhu YB, Qiao H, Sheng ZH. Snapinregulated late endosomal transport is critical for efficient autophagy-lysosomal function in neurons. Neuron. 2010;68:73-86.
30. Shoichi Sasaki. Autophagy in Spinal Cord Motor Neurons in Sporadic Amyotrophic Lateral Sclerosis. J Neuropathol Exp Neurol. 2011;70(5):349-59.
31. Kroemer G, Levine B. Autophagic cell death: The story of a misnomer. Nat Rev Mol Cell Biol. 2008;9:1004-10.
32. Sasaki Y, Vohra BP, Baloh RH, Milbrandt J. Transgenic mice expressing the Nmnat1 protein manifest robust delay in axonal degeneration in vivo. J Neurosci. 2009;29:6526-34.
33. Hetz C, Thielen P, Matus S, Nassif M, Court F, Kiffin R, Martinez G, Cuervo AM, Brown RH, Glimcher LH. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev. 2009;23:2294-3000.
34. Li L, Zhang X, Le W. Altered macroautophagy in the spinal cord of SOD1 mutant mice. Autophagy. 2008;4: 290-293.
35. Nixon RA,Wegiel J, Kumar A, YuWH, Peterhoff C, Cataldo A, Cuervo AM. Extensive involvement of autophagy in Alzheimer disease: An immuno-electron microscopy study. J. Neuropathol. Exp. Neurol. 2005;64:113-22.
36. Webb JL, Ravikumar B, Atkins J. Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem. 2003;278:25009-13.
37. Tellez-Nagel I, Johnson AB, Terry RD. Studies on brain biopsies of patients with Huntington's chorea. J Neuropathol. Exp Neurol. 1974;33:308-32.
38. Banerjee R, Beal MF, Thomas B. Autophgy in neurodegenerative disorders: Pathogenic roles and therapeutic implications. Trends Neurosci. 2010;33(12):541-9.
39. Cheung ZH, Ip NY. Autophagy deregulation in neurodegenerative diseases - -recent advances and future perspectives. J Neurochem. 2011;118:317-25.
40. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, Tanaka K. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441:880-4.
41. Venkatachalam K, Long AA, Elsaesser R, Nikolaeva D, Broadie K, Montell C.Motor deficit in a Drosophila model of mucolipidosis type IV due to defective clearance of apoptotic cells. Cell. 2008;135:838-51.
42. Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: Insights from genetics. Nature Rev Neurosci. 2006;7:710-23.
43. Rosen DR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59-62.
44. Hang F, Strom AL, Fukada K, Lee S, Hayward LJ, Zhu H. Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex. J Biol Chem. 2007;282:16691-9.
45. Crippa V, Sau D, Rusmini P, Boncoraglio A, Onesto E, Bolzoni E Galbiati M, Fontana E, Marino M, Carra S, Bendotti C, De Biasi S, Poletti A. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). Hum Mol Genet. 2010;19:3440-56.
46. Kabuta T, Suzuki Y, Wada K. Degradation of amyotrophic lateral sclerosis-link mutant Cu/Zn-superoxide dismutase proteins by macroautophagy and the proteasome. J Biol Chem. 2006;281:30524-30533.
47. Hanson KA, Kim SH, Wassarman DA, Tibbetts RS. Tibbetts Ubiquilin modifies TDP-43 toxicity in a drosophila model of ALS. J Biol Chem. 2010;285(15):11068- 72.
48. Filimonenko M, Stuffers S, Raiborg C, Yamamoto A, Malerød L, Fisher EM, Isaacs A, Brech A, Stenmark H, Simonsen A. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J Cell Biol. 2007;179:485-500.
49. Wang X, Fan H, Ying Z, Li B, Wang H, Wang G. Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system. Neurosci Lett. 2010; 469(1):112-6.
50. Caccamo A,Majumder S, Deng JJ, Bai Y, Thornton FB, Oddo S. Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability. J Biol Chem. 2009;284:27416-24.
51. Gomes C, Escrevente C, Costa J. Mutant superoxide dismutase1 overexpression in NSC-34 cells: effect of trehalose on aggregation, TDP-43 localization and levels of co-expressed glycoproteins. Neurosci Lett. 2010;475:145-9.
52. Morimoto N, Nagai M, Ohta Y, Miyazaki K, Kurata T, Morimoto M, Murakami T, Takehisa Y, Ikeda Y, Kamiya T, Abe K. Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res. 2007;1167:112-7.
53. Zhang X, Li L, Chen S, Yang D, Wang Y, Zhang X, Wang Z, Le W. Rapamycin treatment augments motor neuron degeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis. Autophagy. 2011;7:412-25.
54. Hadano S, Otomo A, Kunita R, Suzuki-Utsunomiya K, Akatsuka A, Koike M, Aoki M, Uchiyama Y, Itoyama Y, Ikeda JE. Loss of ALS2/Alsin exacerbates motor dysfunction in a SOD1H46R -expressing mouse ALS model by disturbing endolysosomal trafficking. Plos One. 2011;5:e9805.
55. Nixon RA. Autophagy, amloidogenesis and Alzheimer disease. J Cell Sci. 2007;120:4081-91.
56. Kicran D, Hafezparast M, Bohnert S, Dick JR, Martin J, Schiavo G, Fisher EM, Greensmith L. A mutation in dynein rescues anxonal transport defects and extends the life span of ALS mice. J Cell Biol. 2005;169:561-7.
57. Tian F, Morimoto N, Liu W, Ohta Y, Deguchi K, Miyazaki K, Abe K. In vivi optical imaging of motor neuron autophagy in a mouse of amyotrophic lateral sclerosis. Autophagy. 2011;7:985-92.
58. Hadano S, Kunita R, Otomo A, Suzuki-Utsunomiya K, Ikeda JE. Molecular and cellular function of ALS2/alsin: Implication of membrane dynamics in neuronal development and degeneration. Neurochem Int. 2007;51:74-84.
59. Babst M, Katzmann DJ, Estepa-Sabal EJ, Meerloo T, Emr SD. Escrt-III: An endosome-associated heterooligomeric protein complex required for mvb sorting. Dev Cell. 2002;3: 271-82.
60. Cox LE, Ferraiuolo L, Goodall EF, Heath PR, Higginbottom A, Mortiboys H, Hollinger HC, Hartley JA, Brockington A, Burness CE, Morrison KE, Wharton SB,Grierson AJ, Ince PG, Kirby J, Shaw PJ. Mutations in CHMP2B in Lower Motor Neuron Predominant Amyotrophic Lateral Sclerosis (ALS). Plos One. 2010;5:e9872.
61. Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, SiddiqueN, Yang Y, Fecto F, Shi Y, Zhai H, JiangH,HiranoM, Rampersaud E, Jansen GH, Donkervoort S, Bigio EH, Brooks BR, Ajroud K, Sufit RL, Haines JL, Mugnaini E, Pericak-Vance MA, Siddique T. Mutations in UBQLN2 cause dominant Xlinked juvenile and adult-onset ALS and ALS dementia.Nature. 2011;477:211-5.
62. Lindholm D, Wootz H, Korhonen L. ER stress and neurodegenerative diseases. Cell Death Differ. 2006;13:385-92.
63. Yamamoto K, Hamada H, Shinkai H, Kohno Y, Koseki H, Aoe T. The KDEL receptor modulates the endoplasmic reticulum stress response through mitogen-activated protein kinase signaling cascades. J Biol Chem. 2003;278:34525-32.
64. Wang P, Li B, Zhou L, Fei E, Wang G. The KDEL receptor induces autophagy to promote the clearance of neurodegenerative disease-related proteins. Neuroscience. 2011;190: 43-55.
65. Sarkar S, Krishna G, Imarisio S, Saiki S, O'Kane CJ, Rubinsztein DC. A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin. Hum Mol Genet. 2008;17:170-178.
66. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E, Miller RA. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460:392-5.
67. Malagelada C, Jin ZH, Jackson-Lewis V, Przedborski S, Greene LA. Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease. J Neurosci. 2010;30:1166-75.
68. Dehay B, Bov'E J, Rodr'iguez-Muela N, Perier C, Recasens A, Boya P, Vila M. Pathogenic lysosomal depletion in Parkinson's disease. J Neurosci. 2010;30:12535-44.
69. Caccamo A, Maldonado MA, Majumder S, Medina DX, Holbein W, Magr'i A, Oddo S. Naturally secreted amyloid-β increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism. J Biol Chem. 2011;286:8924-32.
70. Cherra SJ 3rd, Chu CT. Autophagy in neuroprotection and neurodegeneration: A question of balance. Future Neurol. 2008;3(3):309-23.
71. Cheung ZH, Ip NY. The emerging role of autophagy in Parkinson's disease. Mol Brain. 2009;2:29.
72. Scarlatti F, Granata R, Meijer AJ, Codogno P. Does autophagy have a license to kill mammalian cell? Cell DeathDiffer. 2009;16(1):12-20.
73. Wong AS, Lee RH, Cheung AY, Yeung PK, Chung SK, Cheung ZH, Ip NY. Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson's disease. Nat Cell Biol. 2011;13: 568-79.
74. Wong E, Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci. 2010;13:805-11.
75. Massey AC, Kaushik S, Sovak G, Kiffin R, Cuervo AM. Consequences of the selective blockage of chaperone-mediated autophagy. Proc Natl Acad Sci USA. 2006;103:5805-10.
76. Nishida Y, Arakawa S, Fujitani K, Yamaguchi H, Mizuta T, Kanaseki T, Komatsu M, Otsu K, Tsujimoto Y, Shimuzu S. Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature. 2009;461:654-8.
77. Fornai F, Longone P, Cafaro L, Kastsiuchenka O, Ferrucci M, Manca ML, Lazzeri G, Spalloni A, Bellio N, Lenzi P, Modugno N, Siciliano G, Isidoro C, Murri L, Ruggieri S, Paparelli A. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci. 2008;105:2052-57.
78. Fornai F, Longone P, Ferrucci M, Lenzi P, Isidoro C, Ruggieri S, Paparelli A. Autophagy and amyotrophic lateral sclerosis: The multiple roles of lithium. Autophagy. 2008;4(4):527-30.
79. Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, Cook LJ, Rubinsztein DC. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 2005;170:1101-11.
80. Stambolic V, Ruel L, Woodgett Jr. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol. 1996;6:1664-68.
81. Pasquali L, Busceti CL, Fulceri F. Intracellular pathway underlying the effects of lithium. Behav Pharmacol. 2010; 21(5-6):473-92.
82. Gill A, Kidd J, Vieira F, Thompson K Perrin S. No benefit from chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinded trial using a standard mouse model of familial ALS. Plos One. 2009;4:e6489.
83. Chio A, Borghero G, Calvo A, Capasso M, Caponnetto C, Corbo M, Giannini F, Logroscino G, Mandrioli J, Marcello N, Mazzini L, Moglia C, Monsurrò MR, Mora G, Patti F, Perini M, Pietrini V, Pisano F, Pupillo E, Sabatelli M, Salvi F, Silani V, Simone IL, Sorarù G, Tola MR, Volanti P, Beghi E. LITALS Study Group. Lithium carbonate in amyotrophic lateral sclerosis: Lack of efficacy in a dose-finding trial. Neurology. 2010;75:619-25.
84. Bov'E J, Mart'inez-Vicente M, Vila M. Fighting neurodegeneration with rapamycin: Mechanistic insights. Nat Rev Neurosci. 2011;12:437-52.